VIR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 113918 min ago

@ $9.72

Wydano: 14 vas. 2024 @ 20:10

Zwrot: 6.89%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 6.58 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	1.66M
Średni wolumen	1.04M
Kapitalizacja rynkowa	1.41B
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $-1.050 ) 2024-05-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.26
ATR14	$0.0190 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-03	De Backer Marianne	Sell	72 995	Common Stock
2024-04-01	Hanly Ann M.	Sell	2 711	Common Stock
2024-03-27	Lee Sung	Sell	6 008	Common Stock
2024-02-22	Hanly Ann M.	Buy	32 500	Common Stock
2024-02-22	Hanly Ann M.	Sell	12 296	Common Stock

INSIDER POWER
-10.23
Last 98 transactions
Buy: 8 177 990 \| Sell: 9 772 896

Wolumen Korelacja

Długi: 0.28 (neutral)

Krótki: -0.96 (very strong negative)

Signal:(36.456) Neutral

Vir Biotechnology Inc Korelacja

10 Najbardziej pozytywne korelacje
MMAC	0.954
BOCH	0.943
NETE	0.913
TERN	0.867
SHSP	0.859
RAVN	0.843
AMRB	0.843
PTPI	0.836
USLB	0.827
ATER	0.826

10 Najbardziej negatywne korelacje
PAIC	-0.934
RMRM	-0.927
SVOK	-0.922
SVAC	-0.888
ISNS	-0.888
APOP	-0.887
FEYE	-0.874
GAINL	-0.872
SPRT	-0.837
TDAC	-0.828

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vir Biotechnology Inc Korelacja - Waluta/Towar

-0.33
( neutral )

-0.62
( weak negative )

0.00
( neutral )

0.46
( neutral )

-0.46
( neutral )

Vir Biotechnology Inc Finanse

Annual	2023
Przychody:	$86.18M
Zysk brutto:	$63.96M (74.22 %)
EPS:	$-4.59

FY	2023
Przychody:	$86.18M
Zysk brutto:	$63.96M (74.22 %)
EPS:	$-4.59

FY	2022
Przychody:	$1.58B
Zysk brutto:	$1.43B (90.74 %)
EPS:	$3.89

FY	2021
Przychody:	$1.10B
Zysk brutto:	$1.03B (93.99 %)
EPS:	$4.44

Financial Reports:

No articles found.

Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.